Clinical Trials

Phase NA Not yet recruiting

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT07478757 2026-03-17

Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized Controlled Trial in Hong Kong

15,000 enrolled

Lung Neoplasms

NCT03151564 2026-03-05

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

146 enrolled

Phase 2 Active not recruiting

Colonic Neoplasms, Digestive System Diseases, Colorectal Neoplasms

NCT03789240 2026-03-03

Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma

33 enrolled 17 charts

Phase 1 Not yet recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT07417488 2026-02-27

GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas

18 enrolled

Colorectal Neoplasms

NCT03388619 2026-02-23

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

Phase 1 Completed

30 enrolled 16 charts

Prostatic Neoplasms

NCT07416825 2026-02-18

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

23 enrolled

Phase 1/2 Active not recruiting

Esophageal Neoplasms

NCT04432597 2026-02-17

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

39 enrolled

GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

NCT07383454 2026-02-03

Lung Cancer Screening in Population Who Had Never Smoked

Phase NA Not yet recruiting

2,500 enrolled

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Small Cell Lung Carcinoma

NCT02297672 2026-02-02

PBSI

75 enrolled

Breast Neoplasms

NCT06865677 2026-01-21

Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas

Phase 2 Terminated

2 enrolled 7 charts

Recurrence

NCT06122610 2026-01-15

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Phase 1 Recruiting

10 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT05035407 2025-12-02

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

Phase 1 Terminated

36 enrolled 7 charts

Carcinoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

GastrointestinalGenitourinaryGynecologic

43 enrolled 13 charts

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT05009979 2025-08-28

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

Phase 2 Terminated

8 enrolled 14 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

11 enrolled 14 charts

CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

NCT02769962 2025-07-28

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

Phase 1/2 Completed

45 enrolled 30 charts

GenitourinaryThoracic

Carcinoma, Transitional Cell, Lung Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT07062172 2025-07-14

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

1,753 enrolled

Lung Neoplasms

NCT00001337 2025-06-22

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

348 enrolled 15 charts

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

94 enrolled 20 charts

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT03824535 2025-04-09

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

15 enrolled 7 charts

Smoking Cessation, Multiple Pulmonary Nodules

NCT03142802 2025-02-10

Low-Dose CT - Stage I Testicular Cancer

251 enrolled

Testicular Neoplasms

NCT06082492 2025-02-05

NVALT31-PET

690 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06793657 2025-01-27

Poppy Seed Use in Gastroenteric Fistula Diagnosis

Phase EARLY_PHASE1 Completed

100 enrolled

Fistula

NCT04510311 2025-01-10

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

32 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT06626178 2024-10-03

ARIA

2,840 enrolled

Lung Neoplasms

NCT04933617 2024-07-09

Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas

Phase 1 Terminated

8 enrolled 17 charts

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT06136065 2024-06-04

FAPI

Phase 2 Unknown

100 enrolled

Other solid neoplasm

Solid Tumor, Unspecified, Adult

NCT01851369 2024-05-08

TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

Phase 1/2 Completed

93 enrolled 27 charts

GastrointestinalLymphoid

Colonic Neoplasms, Lymphoma

NCT02922283 2024-05-06

IL2 Imaging in Metastatic Melanoma

Phase NA Terminated

19 enrolled

Dermatologic

Melanoma

NCT05775822 2024-02-07

RadioTherapy

92 enrolled

Breast Neoplasms, Coronary Artery Disease

NCT04938804 2024-01-09

Non-risk Based Lang Cancer Screening With a One-off LDCT

11,000 enrolled

Phase NA Not yet recruiting

Lung Neoplasms

NCT06157957 2023-12-27

CASSANDRA

40,000 enrolled

Disease, Lung Neoplasms, Tobacco Use Cessation

NCT06016335 2023-12-19

MRI-based Synthetic CT Images of the Head and Neck

80 enrolled

Head & Neck

Cholesteatoma, Head and Neck Neoplasms, Sinusitis, Hearing Loss

NCT03089606 2023-11-15

Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker

Phase EARLY_PHASE1 Completed

27 enrolled 14 charts

Dermatologic

Melanoma

NCT02683824 2023-09-21

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

21 enrolled

Pancreatic Neoplasms

NCT02809690 2023-09-07

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Phase 1 Terminated

18 enrolled

Prostatic Neoplasms

NCT05814224 2023-04-14

MAGNETIC1

164 enrolled

Breast Diseases, Breast Neoplasms

NCT03718260 2023-03-17

PREP

3,070 enrolled

Prostatic Neoplasms

NCT00584233 2022-12-06

Evaluation of Breast CT

75 enrolled 7 charts

Breast Neoplasms

NCT02130427 2022-07-22

A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy

GastrointestinalHead & Neck

74 enrolled 8 charts

Gastrointestinal Neoplasms, Head and Neck Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT03975504 2022-06-01

China Lung Cancer Screening (CLUS) Study Version 2.0

6,000 enrolled

Lung Neoplasms

NCT05362539 2022-05-05

Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria

246 enrolled

Urinary Bladder Neoplasms, Hematuria

NCT04217655 2021-12-29

Low-dose Computed Tomography-guided Core Needle Biopsy for Lung Nodules

200 enrolled

Lung Neoplasms

NCT04740346 2021-10-27

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)

886 enrolled

Recurrence, Stomach Neoplasms

NCT03125629 2021-04-09

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

53 enrolled 8 charts

Cancer Diagnosis

NCT00775268 2021-03-11

18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma

Phase 1/2 Terminated

31 enrolled 18 charts

Lymphoma

NCT04735445 2021-02-03

IMPACNEO

4,638 enrolled

Acquired Immunodeficiency Syndrome, Disease, Neoplasms

NCT02611882 2020-12-22

PSMA PET

225 enrolled 12 charts

Prostatic Neoplasms

NCT04414956 2020-06-04

Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma

1,418 enrolled